Rating: Buy — Conviction: High
Cognizant trades at about 12x this year's adjusted EPS guide and an ~8.4% free-cash-flow yield, close to the model's Bear case. That price assumes AI shrinks its labor-based revenue. The filings don't show that yet: organic growth near 4%, a ~1.3x trailing book-to-bill, margins expanding for a third year, and ~3% of shares retired a year. Market fear about AI deflation in IT services gives a margin of safety that the Base case doesn't need to beat.
Conviction tests (3a-v-c): T1 pass (Base +14.5% at +1pp, +41.3% at −1pp; Buy at both) · T2 pass (Gordon alone +40.9%, exit-multiple alone +11.4%; Buy on both, the exit leg thinly) · T3 pass (every FY0 fact and historical series from EDGAR XBRL, the Q2 2026 10-Q and release, or the 2026-10-06 8-K; no est. inputs) · T4 pass (the open legal items, the India tax case at $349mm and the Syntel appeal at ~$298mm, are each ~1% of market cap)
The rule gives High. The thinnest leg is T2's exit-only reading (+11.4%). If a reviewer reads that as Hold, conviction is Medium.
Business overview
Cognizant sells IT services, mostly application development and maintenance, cloud and infrastructure work, digital engineering and business-process outsourcing, to large enterprises. About 75% of revenue is from North America. FY2025 revenue was $21.1bn, up 6.4% in constant currency, of which 2.6pp came from the Belcan acquisition. Q2 2026 revenue by segment was Financial Services 32%, Health Sciences 29%, Products & Resources 24% and Communications, Media & Technology 16%. About 73% of its ~357,000 staff are in India, so revenue is in dollars and most costs are in rupees. Three variables drive earnings:
- the organic volume of outsourcing and project work, which large deals and renewals set;
- price per unit of work, as AI tooling cuts the hours a deliverable needs;
- the spread between Indian wage inflation and bill rates, adjusted for the rupee, which sets the ~16% adjusted operating margin.
Competition
The 2025 10-K names Accenture, Infosys, TCS, Wipro, HCL, Capgemini, EPAM and IBM Consulting as direct competitors. On growth, Cognizant is ahead of the Indian group. Its Q2 2026 revenue grew 4.1% in constant currency, and Financial Services grew 11.7%. TCS grew 2.8% in constant currency in its September 2026 quarter, and Infosys cut its FY27 (March year-end) guide to 1.5–3.0%, which includes ~1.7pp from acquisitions. Pressure would show up first in renewal pricing and in clients' in-house delivery centers (GCCs, which the 10-K flags). On the Q2 call, management said one in four Global 2000 companies had paused AI deployments. Wipro, the closest listed comparable by delivery model, trades at 8.96x aggregator EV/EBITDA and 13.4x forward P/E, against Cognizant's 7.87x and 11.2x (stockanalysis.com, 2026-10-20 close).
Bull case
- Organic growth holds above peers and reaches ~6%. TTM bookings of $29.1bn (+5%, ~1.3x book-to-bill) and seven $100mm+ deals in Q2 ramp into revenue. AI, data and Anthropic/Google partner work adds scope faster than it removes hours. Plays out if 2027 organic growth is guided at or above ~4% and bookings stay above 1.2x revenue. Model: rev_growth
- Project Leap lifts margin to ~20%. The $230–320mm program restructures delivery around AI-led productivity. Once its charges roll off, model-basis EBITDA margin rises from 18.7% to 20%. Plays out if the 2027 adjusted operating margin is guided above 16.5%. Model: ebitda_margin
- The multiple moves toward Indian peers. The stock exits at 9.5x model-basis EBITDA, up from 7.95x today, still below Infosys and Accenture. Model: exit_ev_ebitda
Bear case
- AI deflates the labor pool. AI productivity in maintenance and BPO renewals outruns new scope. Organic revenue is about flat in 2027 and falls 1.5% in 2028, the industry's direction if TCS-like ~3% growth fades further. Plays out if 2027 organic guidance is under 1%, or headcount falls while revenue stalls. Model: rev_growth
- Leap savings get passed to clients. Renewal price concessions and Indian wage inflation push model-basis margin to 16.5%, below FY2024's 17.4%. Plays out if adjusted operating margin falls below 15.5% in 2027. Model: ebitda_margin
- Permanent de-rating. The market values Cognizant as a shrinking labor business: a 6.0x exit and a 1pp higher discount rate. Model: exit_ev_ebitda, wacc
Valuation & balance sheet
| Metric (definition) | Current | Own history (range or 5y avg) | Peers | Source, as-of |
|---|---|---|---|---|
| EV/EBITDA, model basis (EV $31.3bn = mkt cap $30.8bn − cash $1.05bn + bank debt $1.55bn; EBITDA = GAAP operating income + D&A; leases excluded) | 7.95x FY2025 | n/a (unverified) | aggregator TTM: ACN 10.57x · INFY 10.30x · WIT 8.96x · EPAM 8.10x (CTSH 7.87x on that basis) | model-inputs.json; stockanalysis.com 2026-10-20 close |
| P/E | 11.8x the $5.70–5.82 2026 adjusted EPS guide; 15.0x FY2025 GAAP $4.56 (includes a one-time $390mm non-cash OBBBA tax charge, $0.80/sh) | n/a (unverified) | forward: ACN 16.31x · INFY 14.43x · WIT 13.41x · EPAM 9.64x (CTSH 11.23x) | stockanalysis.com 2026-10-20; Q2 2026 release; 2025 10-K |
| FCF yield (FY2025 OCF $2,883mm − capex $288mm, over mkt cap) | 8.4% (aggregator TTM 8.46%) | n/a (unverified) | ACN 8.23% · INFY 7.88% · WIT 7.97% · EPAM 7.16% | EDGAR XBRL; stockanalysis.com 2026-10-20 |
Model-implied value range (from model-summary.json; generic module, Gordon-growth DCF and exit-EV/EBITDA DCF, midpoints): Bear $54.95 · Base $86.02 · Bull $121.91 per share, i.e. implied returns of −19.4% / +26.2% / +78.8% vs $68.18. These ranges show how the bull and bear drivers translate into value; they are not price targets.
- What's priced in. The price sits 56% of the way from Bear to Base: the market is pricing a good deal of the AI-deflation bear case.
- Re-rating. Base's 7.5x exit is a 5.7% de-rating from today's 7.95x model-basis multiple. The two methods differ by 26% (Gordon $96.05, exit $75.98). At a 9.1% WACC and 2.5% terminal growth, the Gordon method embeds a terminal multiple near 10x, a re-rating of about a quarter. The exit method, alone +11.4%, is the conservative read, and the call does not rest on Gordon.
- Acquisitions. 2026 growth includes acquisitions already closed and paid for, such as Astreya ($634mm, June 2026). From 2027 on, growth is organic only, with no deal spend.
- No tail run. No segment or client is ≥50% of revenue (the largest segment is 32%), and Bear is a decline, not a plateau.
- Excluded upside. The Syntel judgment (~$298mm, under appeal, ~$0.66/sh, ~1% of market cap) is not booked by the company and not counted here.
Balance sheet: net leverage 0.13x FY2025 EBITDA (gross 0.39x). Net debt is ~$0.5bn after $1.6bn of H1 2026 buybacks and the revolver-funded Astreya deal. Interest coverage is 52.9x. The nearest material maturity is October 2031: the $550mm term loan and the ~$1.0bn drawn on the $1.85bn revolver, both refinanced on 2026-10-05, unsecured, under a 3.50x leverage covenant. Ratings: n/a (unverified). Separately, $365mm sits on deposit with India's tax department against a $349mm disputed assessment on the 2016 buyback. It is excluded from cash.
Model note: tier full, status built, verification verified (3,207 formula cells matched in LibreOffice). No unverified inputs and no assumptions without a basis. Scenario consistency is OK on all 14 rows.
- Sourcing. Revenue, operating income, D&A, working-capital lines, capex, acquisitions, buybacks and dividends come from EDGAR XBRL 10-K annual values for FY2021–25. Cash and shares come from the Q2 2026 10-Q and release, and debt from the 2026-10-06 8-K.
- EBITDA basis. GAAP, so Project Leap charges and stock compensation stay in as costs. FY2025 includes a $62mm property-sale gain.
- EPS vs guidance. Base Y1 EPS $5.78 is 0.4% above the $5.76 adjusted guide midpoint. The model is on a GAAP basis that absorbs Leap charges net of the $81mm India provident-fund reversal.
- Placeholders and shares. Bank-debt coupons (4.8%) are display-only estimates. The share count is 452mm outstanding at 2026-06-30, not a diluted figure.
| Metric | CTSH | ACN | INFY | WIT | EPAM | Peer median | vs median |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 14.7x | 17.6x | 14.5x | 13.8x | 17.7x | 16.1x | −9% |
| P/E (forward) | 11.2x | 16.3x | 14.4x | 13.4x | 9.6x | 13.9x | −19% |
| PEG | 1.5x | 2.4x | n/a | n/a | 1.1x | 1.7x | −14% |
| EV/EBITDA (TTM) | 7.9x | 10.6x | 10.3x | 9.0x | 8.1x | 9.6x | −18% |
| EV/Sales (TTM) | 1.5x | 1.9x | 2.3x | 1.7x | 1.1x | 1.8x | −18% |
| P/B | 2.1x | 4.5x | 5.0x | 2.3x | 1.9x | 3.4x | −37% |
| FCF yield | 8.5% | 8.2% | 7.9% | 8.0% | 7.2% | 7.9% | +0.5pp |
As of 2026-10-21. One source and one definition for every company: aggregator TTM and consensus-forward multiples, EV netting reported cash and including lease liabilities in debt. Not the model's own EV basis (see the report's valuation table). Pages fetched 2026-10-21 before the open; quotes are the 2026-10-20 close (4:00pm ET). Dashed line = peer median. Source: stockanalysis.com /stocks/<ticker>/statistics/, fetched 2026-10-21.
Notes. PEG as given by the source, resting on its consensus growth estimates; the source shows none for Infosys or Wipro. CTSH's 7.87x uses the source's $4.04bn TTM EBITDA; on the model's basis (FY2025 GAAP operating income + D&A, leases excluded) it is 7.95x.
Scenario stress test
Reasoned from the bull/bear drivers above. The model column comes from the scenario overlays (Base case + shock).
| Scenario | Effect | Mechanism | Magnitude | Model Δ value vs Base ($/sh) |
|---|---|---|---|---|
| S1 Fast equity crash | − | Liquidity de-rating of a 0.85-beta large cap; small net debt, no funding channel | Med | −$4.33 |
| S2 Slow bear / recession | − | Discretionary projects and P&R/CMT budgets are cut first, and outsourcing contracts cushion them. Milder than Base − Bear ($31) because it is a two-year cycle, not a permanent shrinking of the labor pool | High | −$12.45 |
| S3 Rapid rate shock | − | Higher discount rate; floating-rate bank debt is only $1.55bn | High | −$8.95 |
| S4 Slow rate grind | − | Grinding rates slow client transformation budgets | Med | −$6.23 |
| S5 Soft-landing cuts | + | Confidence restarts discretionary spend | Med | +$7.17 |
| S6 Recession-driven cuts | − | Project cancellations, mostly offset in value by lower rates | Low | −$1.99 |
| S7a Credit liquidity shock | − | De-rating only; leverage ~0.4x EBITDA | Low | −$3.10 |
| S7b Slow default cycle | − | Financial Services (~32% of revenue, the growth engine) trims spend | Low | −$3.19 |
| S8 Stagflation | − | Indian wage inflation outruns bill rates while budgets tighten | High | −$9.02 |
| S9a Dollar spike | ± | ~25% of revenue is outside North America, but most costs are in rupees, so a translation loss is offset by cost relief | Low | −$0.41 |
| S9b Dollar slide | ± | Mirror image: translation gain, rupee cost hit | Low | +$0.41 |
| S10 Melt-up | + | A low-multiple large cap re-rates in a risk-on tape | Med | +$6.54 |
| S11 Energy supply shock | − | Indirect: energy costs squeeze European and manufacturing (P&R) budgets | Low | −$3.60 |
| S12 Mega-cap/AI derating | ± | Smaller AI-disruption discount on services vs lower tech-client (CMT) budgets; roughly offsetting | Low | +$0.95 |
Currently active/on watch per the playbook: S3 partially active (price-level leg only); S8, S10 and S11 on watch.
What would change the call
Downgrades to Hold if: the stock re-rates toward the Base midpoint with no improvement in the data. Also if 2027 organic growth is guided below ~2%, adjusted operating margin falls below 15.5%, or TTM book-to-bill drops under 1.1x. Downgrades to Sell if: organic revenue turns negative, as in the Bear case, while the price still reflects Base.
Watch items
- W1: Q3 2026 revenue — within $5.60–5.68bn (+3.8–5.3% cc) — Q3 2026 release — late Oct 2026 (date not verified) — Model: rev_growth
- W2: Margin and Leap — FY2026 adjusted operating margin within 16.0–16.2%, and cumulative Leap charges within $230–320mm — Q4 2026 release — ~Feb 2027 — Model: ebitda_margin
- W3: 2027 guide — organic growth at or above ~3.5% (Base) vs under 1% (Bear) — Q4 2026 release — ~Feb 2027 — Model: rev_growth
- W4: Bookings — TTM book-to-bill ≥1.2x (Q2 2026: ~1.3x, $29.1bn) — quarterly releases — through 2027 — Model: rev_growth
Sources
- Cognizant (CTSH) statistics — https://stockanalysis.com/stocks/ctsh/statistics/ — accessed 2026-10-21
- Accenture, Infosys, Wipro, EPAM statistics — https://stockanalysis.com/stocks/acn/statistics/ · /infy/ · /wit/ · /epam/ — accessed 2026-10-21
- EDGAR XBRL companyfacts, CIK 0001058290 — https://data.sec.gov/api/xbrl/companyfacts/CIK0001058290.json — accessed 2026-10-21
- Cognizant Reports Second Quarter 2026 Results — https://news.cognizant.com/2026-07-29-Cognizant-Reports-Second-Quarter-2026-Results — accessed 2026-10-21
- Cognizant Form 10-Q, Q2 2026 — https://www.sec.gov/Archives/edgar/data/1058290/000105829026000031/ctsh-20260630.htm — accessed 2026-10-21
- Cognizant Form 10-K, 2025 — https://www.sec.gov/Archives/edgar/data/1058290/000105829026000008/ctsh-20251231.htm — accessed 2026-10-21
- Cognizant Form 8-K, new credit agreement (2026-10-06) — https://www.sec.gov/Archives/edgar/data/1058290/000105829026000033/ctsh-20261005.htm — accessed 2026-10-21
- Q2 2026 call coverage (AI deployment pauses, discretionary assumption) — https://www.webull.com/news/15364343851656192 — accessed 2026-10-21
- Infosys Q1 FY27 guidance cut — https://www.outlookbusiness.com/corporate/infosys-q1-net-profit-rises-12-yoy-to-7769-cr-trims-fy27-revenue-growth-guidance — accessed 2026-10-21
- TCS Q2 FY27 results — https://ticker.finology.in/discover/market-update/tcs-q2-fy27-results-analysis — accessed 2026-10-21
- Macro log, 10Y 5.12% and fed funds on 2026-10-20 — logs/macro-2026-10.md — accessed 2026-10-21